Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, June 7, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Joon Lee Maintained (VRNA) at Strong Buy with Increased Target to $32 on, Jun 7th, 2023
Joon Lee of Truist Securities, Maintained "Verona Pharma plc" (VRNA) at Strong Buy with Increased Target from $28 to $32 on, Jun 7th, 2023.
Joon has made no other calls on VRNA in the last 4 months.
There are 3 other peers that have a rating on VRNA. Out of the 3 peers that are also analyzing VRNA, 0 agree with Joon's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Joon
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $32 on, Friday, June 2nd, 2023
- Edward Nash of "Canaccord Genuity" Maintained at Sell with Increased Target to $33 on, Wednesday, May 10th, 2023
- Thomas Shrader of "BTIG" Maintained at Strong Buy with Increased Target to $31 on, Monday, March 20th, 2023
